Adjuvant treatment of colorectal cancer

Cancer Treatment Reviews

Volumn 23, Issue 3, 1997, Pages 135-152

  Midgley, R S ^a   Kerr, D J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; LEVAMISOLE; MATRIX METALLOPROTEINASE INHIBITOR; OXALIPLATIN; SEMUSTINE; VINCRISTINE;

CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; COLORECTAL CANCER; EUROPE; GENE THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METASTASIS; PORTAL VEIN; SHORT SURVEY;

EID: 0030875029     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(97)90035-9     Document Type: Review

References (61)

1. Abulafi, A. M. & Williams, N. S. (1994) Local recurrence of colorectal cancer: the problems, the mechanisms, management and adjuvant treatment. Br. J. Surg. 81: 7-17.
2. De Wys, W. D. (1972) Studies correlating the growth rate of a tumor and it's metastases and providing evidence for tumor-related systemic growth-retarding factors. Cancer Res. 32: 374-379.
3. Panettriere, F. J., Goodman, P. J., Conkinzi, J. J. et al. (1988) Adjuvant treatment in large bowel adenocarcinoma - long-term results of a Southwest Oncology Group Study. J. Clin. Oncol. 6: 947-955.
4. Higgins, G. A. Jr., Amado, J. H., McElhinney, J. et al. (1984) Efficacy of prolonged intermittent treatment with combined 5-FU and methyl CCNU following resection for carcinoma of the large bowel. Cancer 53: 1-8.
5. Abdi, E. A., Harbora, D., Hanson, J. et al. (1987) Adjuvant chemoimmuno and immunotherapy in stage B and C colorectal carcinoma. Proc. Am. Soc. Oncol. 6: 93.
6. Wolmark, N., Fisher, B., Rockette, H. et al. (1988) Post operative adjuvant chemotherapy or BCG for colon cancer : results from NSABP protocol C-01. J. Natl. Ca. Inst. 80: 30-36.
7. Laurie, J. A., Moertel, C. G., Fleming, T. R. et al. (1989) Surgical adjuvant treatment of large bowel cancer; an evaluation of levamisole and the combination of levamisole and 5-FU. A study of the North Central Cancer Treatment Group (NCCTG) and the Mayo Clinic. J. Clin. Oncol. 7: 1447-1456.
8. Moertel, C. G., Fleming, T. H., MacDonald, J. S. et al. (1990) Levamisole and fluouracil for adjuvant treatment of resected colon cancer. N. Engl. J. Med. 322: 352-358.
9. Goodrich, K. H., Alvarez, X., Holcombe, R. F. et al. (1993) Effect of levamisole on MHC Class I expression in colorectal and breast cancer cell lines. Cancer 72: 225-230.
10. Moertel, C. G., Fleming, T. R., MacDonald, J. S., Haller, D. G. & Laurie, J. A. (1993) Hepatic Toxicity associated with 5-FU plus levamisole adjuvant treatment. J. Clin. Oncol. 11: 2386-2390.
11. Kimmel, D. W. & Schutt, A. J. (1993) Multifocal leukoencephalopathy; occurrence during 5-FU and levamisole treatment and resolution after discontinuation of chemotherapy. Mayo Clin. Proc. 68: 363-365.
12. Chlebowski, R. T., Lillington, L., Nystrom, J. G. & Sayre, J. (1994) Late mortality and levamisole. Adjuvant treatment in colorectal cancer. Br. J. Cancer 69: 1094-1097.
13. NIH Consensus Conference (1990) Adjuvant therapy for patients with colon and rectal cancer. JAMA 264: 1444-1450.
14. King's Fund Forum (1990) Cancer of the colon and rectum. Br. J. Surg. 77: 1063-1065.
15. Gray, R., James, R., Mossman, J. & Stenning, S. (1991) AXIS: a suitable case for treatment. Br. J. Cancer 63: 841-845.
16. Kerr, D. J. (1989) 5-Fluouracil and folinic acid: interesting biochemistry or effective treatment? Br.J.Cancer 60: 807-808.
17. Machover, D., Goldschmidt, E., Chollet, P. et al. (1986) Treatment of advanced colorectal and gatric adenocarcinomas with 5-fluouracil combined with high dose folinic acid. J. Clin. Oncol. 4: 685-696.
18. Machover, D., Schwartzenberg, L., Goldshmidt, E. et al. (1982) Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: A pilot study. Cancer Treat. Rep. 66: 1803-1807.
19. Madajewicz, S., Petrelli, N., Rustum, Y. et al. (1984) Phase I-II trial of high-dose calcium leucovorin and 5-fluouracil in advanced colorectal cancer. Cancer Res. 44: 4667-4669.
20. Buyse, M., Piedbois, P., Rustum, Y. - Advanced Colorectal Analysis Project (1992) Modulation of 5-fluouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J. Clin. Oncol. 10: 896-903.
21. IMPACT trial (1995) Efficacy of adjuvant fluouracil and folinic acid in colon cancer. Lancet 345: 939-944.
22. O'Connell, M., Maillard, J., Kahn, M. J. et al. (1997) Controlled trial of fluouracil and low-dose leucovorin given for 6 months as post operative adjuvant therapy for colon cancer. J. Clin. Oncol. 15: 246-250.
23. Wolmark, N., Rockette, H., Fisher, B. et al. (1993) The benefit of leucovorin modulated 5-fluouracil as post operative adjuvant treatment for primary colon cancer : Results from the Natl. Surg. Adjuv. Breast and Bowel Project protocol C-03. J. Clin. Oncol. 11: 1879-1888.
24. Buyse, M., Zeleniuch-Jacquotee, A. & Chambers, T. C. (1988) Adjuvant therapy of colorectal cancer. Why we still don't know. JAMA 259: 3571.
25. Second report of the MRC Working Party (1984) The evaluation of low-dose pre-operative X-ray therapy in the management of operable rectal cancer: the results of a randomly controlled trial. Br. J. Surg. 71: 21-25.
26. MRC Rectal Cancer Working Party (1996) Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Lancet 348: 1605-1610.
27. MRC Rectal Cancer Working Party (1996) Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Lancet 348: 1610-1614.
28. Higgins, G. A., Humphrey, E., Juler, G., LeVeen, H. H., McCaughan, J. & Keehn, R. J. (1976) Adjuvant chemotherapy in the surgical treatment of large bowel cancer. Cancer 38: 1461-1467.
29. Grage, T. B. & Moss, S. E. (1981) Adjuvant chemotherapy in cancer of the colon and rectum: demonstration of effectiveness of prolonged 5-FU chemotherapy in a prospectively controlled randomised trial. Surg. Clin. North Am. 61: 1321-1329.
30. Fisher, B., Wolmark, N., Rockette, H. et al. (1988) Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J. Natl. Cancer Inst. 80: 21-29.
31. Douglas, H. O. Jr, Moertel, C. G., Mayer, R. J. et al. (1986) Survival after post operative combination treatment of rectal cancer. N. Engl. J. Med. 315: 1294-1295.
32. Krook, J. E., Moertel, C. G., Gunderson, L. L. et al. (1991) Effective surgical adjuvant therapy for high-risk rectal carcinoma. N. Engl. J. Med. 324: 709-715.
33. O'Connoll, M. J., Martenson, J. A., Wieand, H. S. et al. (1994) Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluouracil with radiation therapy after curative surgery. N. Engl. J. Med. 331: 502-507.
34. Wolmark, N., Rockette, H., Mamounas, E. P. et al. (1996) The relative efficacy of 5-fluouracil/ leucovorin, 5-fluouracil/levamisole and 5-fluouracil/leucovorin/levamisole in patients with Dukes B and C carcinoma of the colon : first report of the NSABP protocol C-04. Proc. Am. Soc. Clin. Oncol. 15: 205 (abstract).
35. Haller, D. G., Catalano, P. J., MacDonald, J. S. & Mayer, R. J. (1996) Fluouracil, leucovorin and levamisole. Adjuvant treatment for colon cancer: Preliminary results of INT 0089. Proc. Am. Soc. Clin. Oncol. 15: 211 (abstract).
36. O'Connell, M. J., Laurie, J. A., Shepherd, L. et al. (1996) a prospective evaluation of chemotherapy duration and regimen as surgical adjuvant treatment for high risk colon cancer ; a colloborative trial of the North Central Cancer Treatment Group and the National Cancer Institute of Canada Clinical Trials Group. Proc. Am. Soc. Clin. Oncol. 15: 209 (abstract).
37. QUASAR - A UKCCR Study of Colorectal Cancer Treatment Protocol. UK version, December 1994.
38. Rougier, Ph., Paillot, B., Laplanche et al. (1992) End results of a multicentric randomised trial comparing 5-fluouracil in continuous systemic infusion (Cl) to bolus administration (B) in measurable metastatic colorectal cancer (MCC). Proc. Am. Soc. Clin. Oncol. 11: 163 (abstract).
39. De Grammont, A., Bosset, J. F., Milan, C. et al. (1995) A prospectively randomised trial comparing 5-fluouracil bolus with low-dose folinic acid and 5-fluouracil bolus plus continuous infusion with high dose folinic acid for advanced colorectal cancer. Proc. Am. Soc. Clin. Oncol. 14: 194 (abstract).
40. Leichman, C. G., Fleming, T. R. & Muggia, F. M. (1995) A phase II study of 5-fluouracil and its modulation in advanced colorectal cancer: A Southwest Oncology Group Study. J. Clin. Oncol. 13: 1303-1311.
41. Taylor, I., Machin, D. & Mullee, M. (1985) A randomised controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. Br. J. Surg. 72: 359.
42. Wolmark, N., Rockette, H., Wickerman, D. L. et al. (1990) Adjuvant therapy of Dukes A, B and C adenocarcinoma of the colon with portal vein 5-FU hepatic infusion: preliminary results of NSABP protocol C-02. J. Clin. Oncol. 8: 1466.
43. Sahmoud, T., Rougier, P., Nitti, D. et al. (1996) Adjuvant portal vein infusion of 5-FU and heparin (PVI) in colorectal cancer: An EORTC-GIVIO Intergroup phase III trial. Ann. Oncol. 7 (Suppl. 5): 33 (abstract).
44. AXIS Steering Group (1994) The AXIS colorectal cancer trial: randomisation of over 2000 patients. Br. J. Surg. 81: 1672.
45. Speyer, J. L., Sugarbaker, P. H., Collins, J. M., Dedrick, R. L., Klecker, R. W. & Myers CE (1981) Portal levels and hepatic clearance of 5-fluouracil after IP administration in tumours. Cancer Res. 41: 1916-1922.
46. McArdle, C. S., Kerr, D. J., O'Gorman, P. et al. (1994) Pharmacokinetic study of 5-Fluouracil in a novel dialysate solution; a longterm IP treatment approach for advancedcolorectal cancer. Br. J. Cancer 70: 762-766.
47. Scheithauer, W., Marczell, A., Depish, D. et al. (1996) Combined IV and IP chemotherapy with 5-fluouracil and leucovorin vs 5-Fluouracil and levamisole for adjuvant treatment of resected colon carcinoma. Proc. Am. Soc. Clin. Oncol. 15: 216 (abstract).
48. Jackman, A. L., Taylor, G. A., Gibson, W. et al. (1991) ICI D1964; a quinazoline antifolate thymidylate synthease inhibitor that is a potent inhibitor of L1210 tumour cell growth in vitro and in vivo; a new agent for clinical study. Cancer Res. 51: 5579-5586.
49. Cunningham, D., Zalcberg, J. R., Rath, U. et al. (1995) Tomudex ZD1694: results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leukopenia. Eur. J. Cancer 31A: 1945-1954.
50. Clarke, J. S., Ward, J., De Boer, M. et al. (1994) Phase I study of the new thymidylate synthetase inhibitor "TOMUDEX" ZD1694 in advanced malignancy. Ann. Oncol. 5 (Suppl. 5): 132 (abstract).
51. Zalcberg, J. R., Cunningham, D., Van Cutsem, E. et al. (1996) ZD 1694: A novel thymidylate synthase inhibitor with substantial activity in the treatment of patients with advanced colorectal cancer. TOMUDEX colorectal cancer study group. J. Clin. Oncol. 14: 716-721.
52. Moreau, S., Machover, D., de Gramont, A. et al. (1993) A Phase II trial of oxaliplatin: I-OHP in patients with colorectal cancer previously esistant to 5-fluouracil and folinic acid. Proc. Am. Soc. Clin. Oncol. 12: 645 (abstract).
53. Levi, F., Perpoint, B., Garufi, C. et al. (1993) Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5 day continuous venous infusion at circadian rhythm modulated rate. Eur. J. Cancer 29A: 1280-1284.
54. De Gramont, A., Vignoud, J., Tournigand, C. et al. (1995) Oxaliplatin with high dose folinic acid and 5Fluouracil 48Hr infusion in pre-treated metastatic colorectal cancer (CRC). Eur. J. Cancer 31A:716.
55. Millar, A. & Brown, P. (1996) 360 patient meta-analysis of studies of marimastat - a novel matrix metalloproteinase inhibitor. Annals Oncol. 7 (Suppl. 5): 123 (abstract).
56. Hoover, H. C. Jr., Brandhorst, J. S. & Peters, L. C. (1993) Adjuvant ASI for human colorectal cancer: a 6.5 year median follow-up of a phase III prospective randomised trial. J. Clin. Oncol. 11: 390-399.
57. Herlyn, M., Steplewski, Z., Herlyn, D. & Koprowski, H. (1979) Colorectal carcinoma-specific antigen: detection by means of monoclonl antibodies. Proc. Natl. Acad. Sci. USA. 76: 1438-1442.
58. Herlyn, M., Steplewski, Z., Herlyn, M. F. & Koprowski, H. (1980) Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. Cancer Res. 40: 717-721.
59. Mellstedt, H., Frodin, J. E., Masucci, G. et al. (1991) The therapeutic use of monoclonal antibodies in colorectal carcinoma. Semin. Oncol. 2: 462-477.
60. Riethmuller, G., Schneider-Gadicke, E. & Schlimok, G. (1994) Randomised trial of monoclonal antibody for adjuvant treatment of resected Dukes C colorectal carcinoma. Lancet 343: 1177-1183.
61. Huber, B. E., Austin, E. A., Good, S. S., Knick, V. C., Tibbel, S. & Richards, C. A. (1993) In vivo anti-tumour activity of 5-fluorocytosine on human colorectal cancer cells genetically modified to express cytosine deaminase. Cancer Res. 53: 4619-4626.